Midatech Pharma to Acquire DARA BioSciences

June 4, 2015

Midatech Pharma PLC entered into a merger agreement to acquire DARA BioSciences, with DARA shareholders receiving Midatech ordinary shares via ADRs and a contingent value right (CVR). The deal gives Midatech a U.S. commercial footprint and an expanded oncology supportive-care portfolio; closing was expected in Q3/Q4 2015 subject to customary conditions and ADR listing.

Buyers
Midatech Pharma PLC
Targets
DARA BioSciences, Inc.
Sellers
DARA BioSciences shareholders
Industry
Pharmaceuticals
Location
North Carolina, United States
Transaction Type
Buyout

Explore More

Related articles

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.

Find buyers like these →